Cantitate/Preț
Produs
Total produse
Vezi coșul
Camptothecins in Cancer Therapy de Val R. Adams

Camptothecins in Cancer Therapy: Cancer Drug Discovery and Development

Editat de Val R. Adams
en Limba Engleză Hardback – feb 2005
A critical review our current understanding of camptothecins, their shortcomings, and of the possibilities for improving their clinical performance. The authors discuss new camptothecin analog development, drug delivery issues for optimizing their anticancer activity, and their potential use in a variety of different cancers. Additional chapters describe what is known about the biochemistry, the pharmacology, and the chemistry of the camptothecins, including the mechanism of topoisomerase and how camptothecins poison this enzyme, the use of animal models in defining the anticancer potential of camptothecins, and the question of camptothecin resistance.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 152363 lei  6-8 săpt.
  Humana Press Inc. – 15 noi 2014 152363 lei  6-8 săpt.
Hardback (1) 135327 lei  6-8 săpt.
  Humana Press Inc. – feb 2005 135327 lei  6-8 săpt.

Din seria Cancer Drug Discovery and Development

  • 5% CNS Cancer: Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches
    Preț: 139689 lei
  • 5% Developments in T Cell Based Cancer Immunotherapies
    Preț: 104973 lei
  • 5% mTOR Pathway and mTOR Inhibitors in Cancer Therapy
    Preț: 134080 lei
  • 5% Antiangiogenic Agents in Cancer Therapy
    Preț: 137019 lei
  • 5% Tumor Models in Cancer Research
    Preț: 137541 lei
  • 5% Telomeres and Telomerase in Cancer
    Preț: 131674 lei
  • 5% Gene Therapy for Cancer
    Preț: 136330 lei
  • 5% Proteasome Inhibitors in Cancer Therapy
    Preț: 105400 lei
  • 5% Oncogene-Directed Therapies
    Preț: 106668 lei
  • 24% Protein Tyrosine Kinases: From Inhibitors to Useful Drugs
    Preț: 103759 lei
  • 5% Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention
    Preț: 138872 lei
  • 5% Apoptosis, Senescence and Cancer
    Preț: 135078 lei
  • 5% Bioinformatics in Cancer and Cancer Therapy
    Preț: 134252 lei
  • 5% Bone Metastasis
    Preț: 105458 lei
  • 5% Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy
    Preț: 135293 lei
  • 5% Tumor Suppressor Genes in Human Cancer
    Preț: 135411 lei
  • 5% Platinum-Based Drugs in Cancer Therapy
    Preț: 74082 lei
  • 5% Regional Cancer Therapy
    Preț: 136243 lei
  • 5% Checkpoint Controls and Targets in Cancer Therapy
    Preț: 105088 lei
  • 5% Antifolate Drugs in Cancer Therapy
    Preț: 135847 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy
    Preț: 136582 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology
    Preț: 138372 lei
  • 5% Farnesyltransferase Inhibitors in Cancer Therapy
    Preț: 104832 lei
  • 5% Supportive Care in Cancer Therapy
    Preț: 98218 lei
  • 5% Nucleic Acid Therapeutics in Cancer
    Preț: 68941 lei
  • 5% Stem Cells and Cancer
    Preț: 133176 lei
  • 5% EGFR Signaling Networks in Cancer Therapy
    Preț: 129740 lei
  • 5% Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics
    Preț: 106512 lei
  • 5% Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
    Preț: 135723 lei
  • 5% Hormone Therapy in Breast and Prostate Cancer
    Preț: 105213 lei
  • 5% Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications
    Preț: 131776 lei
  • 5% The Oncogenomics Handbook
    Preț: 138735 lei
  • 5% Macromolecular Anticancer Therapeutics
    Preț: 183685 lei
  • 5% Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions
    Preț: 134338 lei
  • 5% Cancer Drug Resistance
    Preț: 136277 lei
  • 5% Matrix Metalloproteinase Inhibitors in Cancer Therapy
    Preț: 104210 lei
  • 5% Fluoropyrimidines in Cancer Therapy
    Preț: 105126 lei
  • 5% In Vivo Imaging of Cancer Therapy
    Preț: 99058 lei
  • 5% The Tumor Microenvironment
    Preț: 136674 lei
  • 5% Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins
    Preț: 74600 lei
  • 5% Cancer Proteomics: From Bench to Bedside
    Preț: 131172 lei
  • 5% Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
    Preț: 133176 lei
  • 5% COX-2 Blockade in Cancer Prevention and Therapy
    Preț: 105424 lei
  • 5% Cytokines in the Genesis and Treatment of Cancer
    Preț: 136353 lei

Preț: 135327 lei

Preț vechi: 142449 lei
-5% Nou

Puncte Express: 2030
Preț estimativ în valută:
25907€ • 28239$ • 21784£

Carte tipărită la comandă

Livrare economică 17-31 decembrie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781588290274
ISBN-10: 1588290271
Pagini: 476
Ilustrații: XIII, 460 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 0.89 kg
Ediția:2005
Editura: Humana Press Inc.
Colecția Humana
Seria Cancer Drug Discovery and Development

Locul publicării:Totowa, NJ, United States

Public țintă

Research

Cuprins

Biochemistry, Pharmacology, and Chemistry.- Mechanism of Action of Topoisomerase 1 Poisons.- Crystallographic Insight Into the Mechanism of Drug-Induced Topoisomerase I DNA Damage.- Inhibitors of Topoisomerase I Function.- Cytotoxic Mechanisms of Topoisomerase 1 Inhibitors.- Biochemical and Genetic Analyses of DNA Topoisomerase 1-Mediated DNA Damage.- Preclinical Models for Evaluating Topoisomerase I-Targeted Drugs.- Mechanisms of Resistance to Camptothecins.- Recent Advances in Camptothecin Drug Design and Delivery Strategies.- Clinical Perspectives.- Clinical Experience With 9-Aminocamptothecin.- Clinical Studies of Rubitecan (9-Nitro 20(S) Camptothecin).- Irinotecan.- Clinical Experience With Topotecan.- The Clinical Development of Lurtotecan.- Preclinical and Clinical Development of Exatecan (DX-951f).- Camptothecins in the Treatment of Primary Brain Tumors.- Camptothecins in the Treatment of Lung Cancer.- Use of Camptothecins in the Treatment of Leukemia and Related Disorders.

Recenzii

"...an excellent all-around reference appropriate for researchers or clinicians in anticancer drug literature." - Doody's Health Science Book Review Journal

Textul de pe ultima copertă

Clinical interest in the camptothecins continues to expand even though this class of topoisomerase I inhibitors has been studied for almost 50 years, and two early generation members of the family have gained FDA approval. In Camptothecins in Cancer Therapy, leading clinicians and researchers critically review our current understanding of camptothecins, their shortcomings, and the possibilities for improving their clinical performance. The authors discuss new camptothecin analog development, drug delivery issues for optimizing their anticancer activity, and their potential use in a variety of different cancers. Additional chapters describe what is known about the biochemistry, the pharmacology, and the chemistry of the camptothecins, including the mechanism of topoisomerase and how camptothecins poison this enzyme, the use of animal models in defining the anticancer potential of camptothecins, and the question of camptothecin resistance.
Authoritative and up-to-date, Camptothecins in Cancer Therapy provides a comprehensive summary of camptothecin research, as well as a much-needed guide to all the latest information on their optimal therapeutic applications.

Caracteristici

Includes supplementary material: sn.pub/extras